Data as of 12:37pm ET
| +0.16 / +1.56%|
The 7 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 21.00, with a high estimate of 38.00 and a low estimate of 19.00. The median estimate represents a +101.73% increase from the last price of 10.41.
The current consensus among 7 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.